4//SEC Filing
Shah Jatin 4
Accession 0001209191-21-015487
CIK 0001503802other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 8:17 PM ET
Size
7.8 KB
Accession
0001209191-21-015487
Insider Transaction Report
Form 4
Shah Jatin
EVP, Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-25+59,968→ 59,968 totalExercise: $14.56Exp: 2031-02-24→ Common Stock (59,968 underlying) - Award
Common Stock
2021-02-25+22,013→ 107,691 total
Footnotes (3)
- [F1]Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2013 Stock Incentive Plan (the "Plan"). RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in four equal annual installments beginning February 25, 2022.
- [F2]The reporting person has reported prior awards of RSUs in Table II of Form 4. The total reported in Column 5 includes the 22,013 newly awarded RSUs, 33,887 RSUs previously reported in Table II, and 51,791 shares of common stock.
- [F3]This option was granted on February 25, 2021 pursuant to the Plan. The shares underlying this option vest as to 25% of the shares on February 25, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001782186
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 8:17 PM ET
- Size
- 7.8 KB